A super-potent tetramerized ACE2 protein displays enhanced neutralization of SARS-CoV-2 virus infection
Abstract Approaches are needed for therapy of the severe acute respiratory syndrome from SARS-CoV-2 coronavirus (COVID-19). Interfering with the interaction of viral antigens with the angiotensin converting enzyme 2 (ACE-2) receptor is a promising strategy by blocking the infection of the coronaviru...
Guardado en:
Autores principales: | Ami Miller, Adam Leach, Jemima Thomas, Craig McAndrew, Emma Bentley, Giada Mattiuzzo, Lijo John, Ali Mirazimi, Gemma Harris, Nadisha Gamage, Stephen Carr, Hanif Ali, Rob Van Montfort, Terence Rabbitts |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5567762413e2437998e17b082de79177 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Implementing a method for engineering multivalency to substantially enhance binding of clinical trial anti-SARS-CoV-2 antibodies to wildtype spike and variants of concern proteins
por: Adam Leach, et al.
Publicado: (2021) -
Pan RAS-binding compounds selected from a chemical library by inhibiting interaction between RAS and a reduced affinity intracellular antibody
por: Tomoyuki Tanaka, et al.
Publicado: (2021) -
A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS
por: Nicolas Bery, et al.
Publicado: (2020) -
Increased immunogenicity and protective efficacy of influenza M2e fused to a tetramerizing protein.
por: Anne-Marie Carola Andersson, et al.
Publicado: (2012) -
Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies.
por: Xing Zhu, et al.
Publicado: (2021)